Monitoring of minimal residual disease in acute myeloid leukemia-Reference-Cited by-同舟云学术

Monitoring of minimal residual disease in acute myeloid leukemia

Published:2009-11 Issue:6 Volume:21 Page:582-588
ISSN:1040-8746
Container-title:Current Opinion in Oncology
language:en
Short-container-title:Current Opinion in Oncology

Author:

Buccisano Francesco,Maurillo Luca,Spagnoli Alessandra,Principe Maria Ilaria Del,Ceresoli Eleonora,Coco Francesco Lo,Arcese William,Amadori Sergio,Venditti Adriano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference48 articles.

1. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]

2. Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

3. Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

4. A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRD Status and its Prognostic Significance in High-Risk AML Patients: A Single Center Experience;Clinical Lymphoma Myeloma and Leukemia;2017-09

2. Postremission sequential monitoring of minimal residual disease by WT 1 Q‐ PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients;Cancer Medicine;2015-12-29

3. Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia;Leukemia;2015-09-16

4. Different aspects of stem cell procedures in children with poor responding AML: when is HSCT the best answer?;International Journal of Hematologic Oncology;2015-04

5. Minimalna choroba resztkowa w ostrych białaczkach u dzieci i dorosłych;Acta Haematologica Polonica;2014-10